Overview

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To determine the best dose of this investigational agent AG-013736 in combination with various standard of care treatments for advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Albumin-Bound Paclitaxel
Axitinib
Capecitabine
Carboplatin
Cisplatin
Docetaxel
Gemcitabine
Paclitaxel
Pemetrexed